Home Helocyte

Helocyte

In operation
-
Developer of Novel Immunotherapies
Basic
Enterprise Profile

Basic Information

Helocyte, Inc. is a company founded by Fortress Biotech, Inc., focusing on the development and commercialization of novel immunotherapies for the prevention and treatment of cancer and infectious diseases, particularly Cytomegalovirus or "CMV."
Helocyte, Inc.
NewYork,NewYork,United States of America
less than 15 people
January 01, 2015
info@helocyte.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production Biological Product Manufacturing
Technology
Immunological Techniques Cell Technology Microbial/Viral Technology
Concept
Tumor Infectious Diseases
Application Scenarios
Biologics Innovative Drugs Biological Products